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Patient Characteristics
Age (mean) 83.1 years	/ 10.1
Caucasians / African-Americans 84% / 16%
Gender % ( males / females ) 69 / 31
LVEF (mean) 15 %	/ 8%
Co-morbidities
Prior MI 62%
Prior PCI 38%
Diabetes 67%
PVD 64%
CKD ( IV/V) 46%
Prior CABG 28%
Co-morbidity based mortality Risk Scoring
STS – Mean Risk of Procedural Mortality 65%	/ 18.8 %
STS – mean Mortality or morbidity 87.1%	/ 23.7%
Mean EuroSCORE II predicted mortality 52.42%	/ 11.8%
Mean EUROSCORE predicted
mortality(logistic)
66.5%	/ 21%
Mean Parsonnet predicted 30 day mortality 38.9%	/ 13.3%
Aortic Valve Characteristics
AVA Mean Grad
Pre 0.55 45
Post 0.68 32
Results: All patients had uneventful BAVs with this form of Impella support.The
in-hospital mortality was 15% with mean hospital length of stay 6 days 	/ 3.
Conclusions: BAV supported by Impella LVAD in a group of high risk patients
with advanced age and poor cardiac reserve is feasible and efficacious.This
particular algorhythm permits intervention with only a single arterial access.
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Background: The approach of transcatheter aortic valve implantation (TAVI) is
primarily guided by the assessment of iliaco-femoral tract diameter. A minimal diameter
of 6mm of the transfemoral tract is required for transfemoral TAVI. Currently, projection
angiography (XA) and CT-angiography (CTA) are used interchangeably to evaluate
suitability of the iliaco-femoral tract. Discrepancies between XA and CTA remain to be
elucidated. We aim to reveal differences in iliaco-femoral tract diameters of TAVI
candidates assessed by XA and CTA.
Methods: Diameters of 273 prospectively collected iliacofemoral segments of 39 TAVI
candidates were analyzed on both XA and CTA by two observers. We determined the
interobserver agreement for both imaging modalities and the difference between XA and
CTA measurements.
Results: Diameters measured on CTA were on average smaller (mean 8.23.0 mm,
mean difference 1.89 mm [95%CI: 1.65-2.13mm; p0.001]). The interobserver agree-
ment was excellent (Pearson coefficient: 0.92 for XA and 0.93 for CTA). For 21% (8
patients) CTA based diameters would have resulted in withholding a transfemoral
procedure, whilst diameters measured on XA were larger than 6mm.
Conclusions: Diameters on CTA are significantly smaller than XA-based measurements,
which should be acknowledged when determining the TAVI approach. The cut-off value
of 6mm on XA may be lower for CTA.
TCT-881
Embolic Cerebral Insults and Microbleeds after Percutaneous Aortic Valve
Replacement and Surgical Aortic Valve Replacement detected by Magnetic
Resonance Imaging
Stephan Ensminger1, Sabine Ott2, Stephan Achenbach3, Christian Heim2,
Richard Feyrer2, Sabrina Loders2, Arndt Doerfler2, Werner Daniel2,
Michael Weyand2, Josef Ludwig2, Martin Arnold2
1Heart and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen,
Germany, 2University of Erlangen-Nürnberg, Erlangen, Germany, 3University of
Giessen, Giessen, Germany
Background: We have previously shown that there is an increased rate of embolic cerebral
insults after transcatheter aortic valve implantation (TAVI). Cerebral microbleeds have been
identified as a marker for poor neurologic outcome. The aim of this study was to assess and
compare the rate of new periprocedural embolic cerebral insults and microbleeds in patients
after TAVI and surgical AVR by MRI and their respective clinical outcome.
Methods: 48 consecutive patients (18 male, 30 female, mean age 815 years, average log.
Euroscore 3210%) undergoing TAVI received a cranial MRI before and after the TAVI
procedure to detect new cerebral lesions. 44 consecutive patients (26 male, 18 female, mean
age 785 years, average log. Euroscore 1310%) undergoing surgical AVR also received a
baseline cerebral MRI scan preoperatively and MRI was repeated within 6 days after valve
implantation. MRI studies included axial diffusion weighted, T2 weighted, FLAIR-weighted
and T2 gradient echo sequences. Standardized clinical assessment of the neurologic status was
performed prior to aortic valve replacement and before discharge.
Results: In 63% of the TAVI patients new cerebral embolic lesions could be detected in the
postprocedural MRI. The maximal lesion size was  5mm in 10 patients,  10mm in 17
patients and 10mm in 3 patients. Despite the high incidence of morphologically detectable
lesions only a single patient developed relevant neurologic symptoms of a stroke. Within
patients after surgical AVR only 44% of the patients displayed new cerebral embolic lesions.
The maximal lesion size was 5mm in 10 patients, 10mm in 6 patients and 10mm in
3 patients. No clinically relevant strokes were seen in this group. In contrast, cerebral
microbleeds were only detected in 13% of the TAVI patients but in 64% of patients after
surgical AVR.
Conclusions: New embolic cerebral insults and microbleeds detected by MRI were seen
both patient groups (TAVI	surgical AVR). Patients after surgical AVR showed more
microbleeds, whereas patients after TAVI showed more embolic ischemic insults. However,
despite the high percentage of MRI detected lesions in both groups, relevant neurological
symptoms were very rare and mostly transitory.
TCT-882
Has Balloon Aortic Valvuloplasty For Severe Aortic Stenosis Improved
Outcomes In The Transcatheter Aortic Valve Replacement Era?
Itsik Ben-Dor1, Israel Barbash2, Danny Dvir3, Petros Okubagzi2,
Augusto Pichard4, Lowell Satler5, Rebecca Torguson3, Ron Waksman6
1Washington Hospital Center, Washington DC, DC, 2Washington Hospital Center,
Washington, DC, 3Washington Hospital center, washington, DC, 4washsington
hospital center, Washington, USA, 5Washington hospital center, washington, DC,
6Georgtown University, Washington, DC
Background: The introduction of transcatheter aortic valve replacement (TAVR) has led
to a revival in balloon aortic valvuloplasty (BAV) as treatment for patients with severe
aortic stenosis.
Methods: A cohort of 472 patients underwent 538 BAV procedures. The cohort was
divided into two groups: Group I, 296 (55.0%) procedures before 2010 and Group II, 242
(45%) procedures after 2010. Successful BAV was defined as reduction 40% in the
mean gradient and/or increase in aortic valve area 40%. Clinical, hemodynamic, and
follow-up mortality data were collected.
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